Cargando…
A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment
The implementation of immunotherapy has radically changed the treatment of oncological patients. Currently, immunotherapy is indicated in the treatment of patients with head and neck tumors, melanoma, lung cancer, bladder tumors, colon cancer, cervical cancer, breast cancer, Merkel cell carcinoma, l...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936941/ https://www.ncbi.nlm.nih.gov/pubmed/32623581 http://dx.doi.org/10.1007/s12094-020-02442-3 |
_version_ | 1783661292453625856 |
---|---|
author | Leon-Mateos, L. Garcia-Velloso, M. J. García-Figueiras, R. Rodriguez-Moreno, J. F. Vercher-Conejero, J. L. Sánchez, M. Perez Gracia, J. L. Simo-Perdigo, M. Gorospe, L. |
author_facet | Leon-Mateos, L. Garcia-Velloso, M. J. García-Figueiras, R. Rodriguez-Moreno, J. F. Vercher-Conejero, J. L. Sánchez, M. Perez Gracia, J. L. Simo-Perdigo, M. Gorospe, L. |
author_sort | Leon-Mateos, L. |
collection | PubMed |
description | The implementation of immunotherapy has radically changed the treatment of oncological patients. Currently, immunotherapy is indicated in the treatment of patients with head and neck tumors, melanoma, lung cancer, bladder tumors, colon cancer, cervical cancer, breast cancer, Merkel cell carcinoma, liver cancer, leukemia and lymphomas. However, its efficacy is restricted to a limited number of cases. The challenge is, therefore, to identify which subset of patients would benefit from immunotherapy. To this end, the establishment of immunotherapy response criteria and predictive and prognostic biomarkers is of paramount interest. In this report, a group of experts of the Spanish Society of Medical Oncology (SEOM), the Spanish Society of Medical Radiology (SERAM), and Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM) provide an up-to-date review and a consensus guide on these issues. |
format | Online Article Text |
id | pubmed-7936941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-79369412021-03-19 A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment Leon-Mateos, L. Garcia-Velloso, M. J. García-Figueiras, R. Rodriguez-Moreno, J. F. Vercher-Conejero, J. L. Sánchez, M. Perez Gracia, J. L. Simo-Perdigo, M. Gorospe, L. Clin Transl Oncol Special Article The implementation of immunotherapy has radically changed the treatment of oncological patients. Currently, immunotherapy is indicated in the treatment of patients with head and neck tumors, melanoma, lung cancer, bladder tumors, colon cancer, cervical cancer, breast cancer, Merkel cell carcinoma, liver cancer, leukemia and lymphomas. However, its efficacy is restricted to a limited number of cases. The challenge is, therefore, to identify which subset of patients would benefit from immunotherapy. To this end, the establishment of immunotherapy response criteria and predictive and prognostic biomarkers is of paramount interest. In this report, a group of experts of the Spanish Society of Medical Oncology (SEOM), the Spanish Society of Medical Radiology (SERAM), and Spanish Society of Nuclear Medicine and Molecular Imaging (SEMNIM) provide an up-to-date review and a consensus guide on these issues. Springer International Publishing 2020-07-04 2021 /pmc/articles/PMC7936941/ /pubmed/32623581 http://dx.doi.org/10.1007/s12094-020-02442-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Special Article Leon-Mateos, L. Garcia-Velloso, M. J. García-Figueiras, R. Rodriguez-Moreno, J. F. Vercher-Conejero, J. L. Sánchez, M. Perez Gracia, J. L. Simo-Perdigo, M. Gorospe, L. A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment |
title | A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment |
title_full | A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment |
title_fullStr | A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment |
title_full_unstemmed | A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment |
title_short | A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment |
title_sort | multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936941/ https://www.ncbi.nlm.nih.gov/pubmed/32623581 http://dx.doi.org/10.1007/s12094-020-02442-3 |
work_keys_str_mv | AT leonmateosl amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT garciavellosomj amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT garciafigueirasr amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT rodriguezmorenojf amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT vercherconejerojl amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT sanchezm amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT perezgraciajl amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT simoperdigom amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT gorospel amultidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT leonmateosl multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT garciavellosomj multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT garciafigueirasr multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT rodriguezmorenojf multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT vercherconejerojl multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT sanchezm multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT perezgraciajl multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT simoperdigom multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment AT gorospel multidisciplinaryconsensusonthemorphologicalandfunctionalresponsestoimmunotherapytreatment |